Vident Advisory’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $666K | Sell |
39,725
-3,630
| -8% | -$60.8K | 0.01% | 901 |
|
|
2025
Q1 | $666K | Buy |
43,355
+195
| +0.5% | +$3K | 0.01% | 883 |
|
|
2024
Q4 | $951K | Sell |
43,160
-2,327
| -5% | -$51.3K | 0.02% | 658 |
|
|
2024
Q3 | $820K | Sell |
45,487
-1,070
| -2% | -$19.3K | 0.02% | 704 |
|
|
2024
Q2 | $757K | Buy |
+46,557
| New | +$757K | 0.02% | 699 |
|
|
2024
Q1 | – | Sell |
-40,732
| Closed | -$425K | – | 1421 |
|
|
2023
Q4 | $425K | Buy |
40,732
+11,580
| +40% | +$121K | 0.01% | 848 |
|
|
2023
Q3 | $297K | Buy |
+29,152
| New | +$297K | 0.01% | 909 |
|